MetLife, Inc. (NYSE:MET) Shares Purchased by Nordea Investment Management AB

Nordea Investment Management AB lifted its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 9.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,664,012 shares of the financial services provider’s stock after purchasing an additional 240,564 shares during the quarter. Nordea Investment Management AB owned about 0.36% of MetLife worth $176,304,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in MET. Dfpg Investments LLC raised its position in shares of MetLife by 3.4% in the 4th quarter. Dfpg Investments LLC now owns 8,909 shares of the financial services provider’s stock worth $598,000 after buying an additional 289 shares during the period. Farmers Trust Co. increased its position in shares of MetLife by 13.3% during the fourth quarter. Farmers Trust Co. now owns 4,128 shares of the financial services provider’s stock worth $273,000 after acquiring an additional 485 shares during the last quarter. Wedmont Private Capital increased its position in shares of MetLife by 25.9% during the fourth quarter. Wedmont Private Capital now owns 7,315 shares of the financial services provider’s stock worth $509,000 after acquiring an additional 1,503 shares during the last quarter. Trust Co. of Toledo NA OH increased its position in shares of MetLife by 3.6% during the fourth quarter. Trust Co. of Toledo NA OH now owns 33,861 shares of the financial services provider’s stock worth $2,239,000 after acquiring an additional 1,177 shares during the last quarter. Finally, DNB Asset Management AS increased its position in shares of MetLife by 0.5% during the fourth quarter. DNB Asset Management AS now owns 239,368 shares of the financial services provider’s stock worth $15,829,000 after acquiring an additional 1,113 shares during the last quarter. Institutional investors and hedge funds own 88.14% of the company’s stock.

Insider Activity at MetLife

In other news, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the transaction, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.32% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently commented on MET. UBS Group decreased their price target on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research note on Monday, February 5th. Wells Fargo & Company decreased their target price on MetLife from $85.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, February 6th. Keefe, Bruyette & Woods cut their price target on MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Thursday, December 7th. Finally, The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and lifted their price target for the company from $70.00 to $80.00 in a report on Monday, January 8th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, MetLife has a consensus rating of “Moderate Buy” and an average target price of $77.23.

Read Our Latest Stock Report on MET

MetLife Stock Performance

NYSE:MET opened at $72.39 on Monday. The stock has a fifty day moving average price of $69.20 and a 200-day moving average price of $65.36. The company has a market cap of $52.34 billion, a price-to-earnings ratio of 39.56, a PEG ratio of 0.55 and a beta of 1.03. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $72.89.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). The firm had revenue of $18.72 billion during the quarter, compared to the consensus estimate of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. As a group, equities analysts anticipate that MetLife, Inc. will post 8.81 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, March 14th. Stockholders of record on Tuesday, February 6th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.87%. The ex-dividend date was Monday, February 5th. MetLife’s payout ratio is 113.66%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.